Treatment of a mutant KRAS lung cancer cell line with polyisoprenylated cysteinyl amide inhibitors activates the MAPK pathway, inhibits cell migration and induces apoptosis.

Autor: Gregory, Matthew D.1 (AUTHOR), Ofosu-Asante, Kweku1 (AUTHOR), Lazarte, Jassy Mary S.1 (AUTHOR), Puente, Pablo E.2 (AUTHOR), Tawfeeq, Nada1 (AUTHOR), Belony, Nadine3 (AUTHOR), Huang, Yong3 (AUTHOR), Offringa, Ite A.2 (AUTHOR), Lamango, Nazarius S.1 (AUTHOR) nazarius.lamango@famu.edu
Zdroj: PLoS ONE. 10/22/2024, Vol. 19 Issue 10, p1-24. 24p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje